DEST — Destiny Pharma Share News
0.000.00%
- £3.83m
- -£2.55m
RCS - Destiny Pharma PLC - Presentation at ESCMID on XF-73 Nasal Gel
AnnouncementRCS - Destiny Pharma PLC - Exploration of XF drug potential for CF
AnnouncementREG - AIM Destiny Pharma PLC - Cancellation - Destiny Pharma plc
AnnouncementREG - Destiny Pharma PLC - Last Day of Dealings on AIM
AnnouncementREG - Destiny Pharma PLC - Director/PDMR Shareholding
AnnouncementRCS - Destiny Pharma PLC - XF-73 prevents bacterial invasion of bloodstream
AnnouncementREG - Destiny Pharma PLC - Result of GM and Cancellation of Trading on AIM
AnnouncementRCS - Destiny Pharma PLC - Treatment of XF-73 Nasal reduces antibiotic use
AnnouncementREG - Destiny Pharma PLC - Proposed Cancellation of Admission to Trading
AnnouncementREG - Destiny Pharma PLC - Exercise of Options and Total Voting Rights
AnnouncementREG - Destiny Pharma PLC - Efficacy of XF-70 in Fungal Skin Infections
AnnouncementREG - Destiny Pharma PLC - Result of Annual General Meeting
AnnouncementREG - Destiny Pharma PLC - 2024 Annual General Meeting and Statement
AnnouncementREG - Destiny Pharma PLC - Destiny Pharma's XF-73 Nasal Awarded MHRA ILAP
AnnouncementREG - AIM - AIM Notice - 30/05/2024
AnnouncementREG - Destiny Pharma PLC - Exercise of Options and Total Voting Rights
AnnouncementREG - Destiny Pharma PLC - Posting of Annual Report and Notice of AGM
AnnouncementREG - Destiny Pharma PLC - Full year results and review of strategic options
AnnouncementREG - Destiny Pharma PLC - Notice of Full Year Results
Announcement